46 related articles for article (PubMed ID: 16125654)
1. A method to quantify at late imaging a release rate of 18F-FDG in tissues.
Laffon E; Allard M; Marthan R; Ducassou D
C R Biol; 2005 Aug; 328(8):767-72. PubMed ID: 16125654
[TBL] [Abstract][Full Text] [Related]
2. Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
[TBL] [Abstract][Full Text] [Related]
3. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.
Iozzo P; Gastaldelli A; Järvisalo MJ; Kiss J; Borra R; Buzzigoli E; Viljanen A; Naum G; Viljanen T; Oikonen V; Knuuti J; Savunen T; Salvadori PA; Ferrannini E; Nuutila P
J Nucl Med; 2006 Jun; 47(6):1016-22. PubMed ID: 16741312
[TBL] [Abstract][Full Text] [Related]
5. In vivo quantification of 18f-fdg uptake in human placenta during early pregnancy.
Zanotti-Fregonara P; Jan S; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
Health Phys; 2009 Jul; 97(1):82-5. PubMed ID: 19509511
[TBL] [Abstract][Full Text] [Related]
6. Simplifications in analyzing positron emission tomography data: effects on outcome measures.
Logan J; Alexoff D; Kriplani A
Nucl Med Biol; 2007 Oct; 34(7):743-56. PubMed ID: 17921027
[TBL] [Abstract][Full Text] [Related]
7. No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine.
Niederkohr RD; Quon A
Clin Nucl Med; 2007 Apr; 32(4):302-3. PubMed ID: 17413580
[No Abstract] [Full Text] [Related]
8. Measurement of input functions in rodents: challenges and solutions.
Laforest R; Sharp TL; Engelbach JA; Fettig NM; Herrero P; Kim J; Lewis JS; Rowland DJ; Tai YC; Welch MJ
Nucl Med Biol; 2005 Oct; 32(7):679-85. PubMed ID: 16243642
[TBL] [Abstract][Full Text] [Related]
9. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.
Kang WJ; Kang HJ; Kim HS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2006 Aug; 47(8):1295-301. PubMed ID: 16883008
[TBL] [Abstract][Full Text] [Related]
10. Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods.
Greuter HN; Boellaard R; van Lingen A; Franssen EJ; Lammertsma AA
J Nucl Med Technol; 2003 Dec; 31(4):206-9. PubMed ID: 14657286
[TBL] [Abstract][Full Text] [Related]
11. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of 2-deoxy-2-chloro-d-glucose impurity analysis in [(18)F]FDG by three potential-time waveforms of high-performance liquid chromatography/pulsed amperometric detection.
Farn SS; Yeh YH; Lin WJ; Shen LH
Nucl Med Biol; 2009 Feb; 36(2):225-31. PubMed ID: 19217535
[TBL] [Abstract][Full Text] [Related]
13. Operational lumped constant for FDG in normal adult male rats.
Tokugawa J; Ravasi L; Nakayama T; Schmidt KC; Sokoloff L
J Nucl Med; 2007 Jan; 48(1):94-9. PubMed ID: 17204704
[TBL] [Abstract][Full Text] [Related]
14. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
Dunn JT; Anthony K; Amiel SA; Marsden PK
J Cereb Blood Flow Metab; 2009 May; 29(5):1059-67. PubMed ID: 19293824
[TBL] [Abstract][Full Text] [Related]
15. A method to quantify the uptake rate of 2-[18F]fluoro-2-deoxy-D-glucose in tissues.
Laffon E; Allard M; Marthan R; Ducassou D
Nucl Med Commun; 2004 Aug; 25(8):851-4. PubMed ID: 15266182
[TBL] [Abstract][Full Text] [Related]
16. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
Mullani NA; Herbst RS; O'Neil RG; Gould KL; Barron BJ; Abbruzzese JL
J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436
[TBL] [Abstract][Full Text] [Related]
17. Improved quality control of [18F]FDG by HPLC with UV detection.
Nakao R; Ito T; Yamaguchi M; Suzuki K
Nucl Med Biol; 2005 Nov; 32(8):907-12. PubMed ID: 16253817
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET.
Jackson RS; Schlarman TC; Hubble WL; Osman MM
J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biodistribution of 34mCl-labeled 2-chloro-2-deoxy-d-glucose: a major impurity in [18F]FDG injection.
Fukumura T; Takei M; Suzuki K
Appl Radiat Isot; 2008 Dec; 66(12):1905-9. PubMed ID: 18706823
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin stimulates endothelial cell 18F-FDG uptake through focal adhesion kinase-mediated phosphatidylinositol 3-kinase/Akt signaling.
Paik JY; Ko BH; Jung KH; Lee KH
J Nucl Med; 2009 Apr; 50(4):618-24. PubMed ID: 19289426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
